levonorgestrel-releasing intrauterine system

Product Name: Mirena® by Bayer Healthcare Pharmaceuticals
Country: United Kingdom (UK)

NETSCC, HTA – NIHR Coordinating Centre for Health Technology Assessment

Outcome Measure

Primary - Level of satisfaction, Secondary – Surrogate Outcomes for Satisfaction: Major problem resolved/improvement of health state/menstrual symptoms successfully treated/degree of recommendation, bleeding scores, amenorrhoea rate, heavy bleeding rate, EQ-5D utility score, SF-36 scores, postoperative pain score, time to return to work/normal activities/sexual activity, discontinuing use of Mirena (p. 12ff)

Body Classification

Female Reproductive System

Device Type

Delivery device

Device Category

Treatment of disease

Risk Classification



heavy menstrual bleeding, causes: fibroids, polyps, adenomyosis, infection, malignancies